Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic review

BACKGROUND: Current guidelines recommend anthracycline-based chemotherapy primarily with doxorubicin either as monotherapy or in combination with ifosfamide as the first-line treatment for most advanced STS subtypes. Therapeutic options after failure of doxorubicin and/or ifosfamide are limited. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Sheetal, Takyar, Shweta, Manson, Stephanie C, Powell, Sarah, Penel, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765173/
https://www.ncbi.nlm.nih.gov/pubmed/23937858
http://dx.doi.org/10.1186/1471-2407-13-385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765173/
https://www.ncbi.nlm.nih.gov/pubmed/23937858
http://dx.doi.org/10.1186/1471-2407-13-385

Ejemplares similares